MoDC depletion resulted in a significant delay in tumor growth and prolonged survival in comparison with control mice (Fig. 4 B), which correlated with decreased Treg numbers and an increased CD8+ TIL-to-Treg ratio after treatment (Fig. 4 C). Here, CD8A is linked to neoplasm.